Beijing Tongrentang Co., Ltd

600085

CNE000000R69

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-05-30 pm EDT			5-day change	1st Jan Change
44.57 ^CNY	+0.16%		-2.07%	-17.00%

May. 01	Tong Ren Tang Registers Danggui Buxue Granules in Hong Kong	MT
Apr. 30	Tong Ren Tang's Q1 Profit Jumps 10%, Revenue Rises 2%	MT

Beijing Tongrentang Co., Ltd. Announces Cash Dividend for 2019, Payable July 20, 2020

July 12, 2020

The Beijing Tongrentang Co. Ltd. implements the scheme of rights and interests distribution for 2019 as follows: a cash dividend of RMB 0.26 (taxes included) per A share. Record date: July 17, 2020, Ex-dividend date: July 20, 2020 and Cash dividend payable date: July 20, 2020.

Latest news about Beijing Tongrentang Co., Ltd

Tong Ren Tang Registers Danggui Buxue Granules in Hong Kong	May. 01	MT
Tong Ren Tang's Q1 Profit Jumps 10%, Revenue Rises 2%	Apr. 30	MT
Beijing Tongrentang Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 29	CI
Beijing Tongrentang Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 28	CI
China Approves Tong Ren Tang Group's Clinical Trial of Heart Failure Drug	Mar. 06	MT
Beijing Tongrentang Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-30	CI
Chinese listed firms used endangered animal parts as ingredients -report	23-10-23	RE
Three listed Chinese firms used endangered animal parts as ingredients- report	23-10-22	RE
China's crackdowns rewrite investors' private sector playbook	23-08-17	RE
Beijing Tongrentang Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-04	CI
Beijing Tongrentang Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28	CI
Beijing Tongrentang Co., Ltd announced that it expects to receive CNY 33.345 million in funding from Jianzhijia Pharmaceutical Chain Group Co., Ltd.	22-12-28	CI
Beijing Tongrentang Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-27	CI
Beijing Tongrentang Co., Ltd(XSSC:600085) added to S&P Global BMI Index	22-09-19	CI
Beijing Tongrentang Co., Ltd(XSSC:600085) added to FTSE All-World Index	22-09-19	CI
Beijing Tongrentang Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-30	CI
MSCI to add 13 securities to its ACWI index, and delete 8 securities	22-08-11	RE
Beijing Tongrentang Co., Ltd(SHSE:600085) added to SSE 180 Index	22-06-13	CI
Beijing Tongrentang Co., Ltd(SHSE:600085) added to Shanghai Stock Exchange 180 Value Index	22-06-13	CI
Beijing Tongrentang Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-29	CI
Beijing Tongrentang Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-25	CI
Beijing Tongrentang Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-29	CI
Beijing Tongrentang Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-25	CI
China stocks end lower as healthcare, tech firms tumble	21-07-06	RE
China stocks fall on healthcare slump; Hong Kong down	21-07-06	RE

Chart Beijing Tongrentang Co., Ltd

Duration

Period

More charts

Company Profile

BEIJING TONGRENTANG CO., LTD is a China-based company principally engaged in the production and sales of traditional Chinese patent medicines. The Companyâs main products consist of liuwei dihuang series, tongren dahuoluo series, tongren niuhuang qingxin series, angong niuhuang series and donkey-hide gelatin series. The Company distributes its products under the brand of Tongrentang. The Company is also involved in the operation of Tongrentang drug stores. The Company distributes its products in domestic market and to overseas markets.

Sector

Pharmaceuticals

Calendar

2024-06-13 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Ratings for Beijing Tongrentang Co., Ltd

Trading Rating

Investor Rating

ESG Refinitiv

C-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

44.57 CNY

Average target price

54.27 CNY

Spread / Average Target

+21.75%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
BEIJING TONGRENTANG CO., LTD	-17.00%	8.44B
ELI LILLY AND COMPANY	+40.73%	739B
NOVO NORDISK A/S	+32.83%	598B
JOHNSON & JOHNSON	-6.30%	353B
MERCK & CO., INC.	+15.15%	318B
ABBVIE INC.	+4.05%	285B
ASTRAZENECA PLC	+15.00%	240B
ROCHE HOLDING AG	-5.52%	206B
AMGEN INC.	+6.17%	164B
PFIZER, INC.	-0.45%	162B

Other Pharmaceuticals